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         Constitutive  isoforms of nitric oxide synthase (NOS) are activated by transient binding of 
Ca2+/calmodulin (CaM).  Here, we have developed a solution phase radioligand binding assay to 
characterize the binding of CaM to purified neuronal NOS (nNOS).   [125I]CaM bound to a single class 
of non-interacting and high affinity sites on nNOS homodimers with Kd = 4.7\ nM.  [125I]CaM binding 
at 23°C achieved rapid saturation, was linear with nNOS concentration, and exhibited a strict 
dependence on [Ca2+] (EC50  = 202 nM).  Neither affinity nor extent of [125I]CaM binding was affected 
by nNOS substrates and cofactors L-arginine, NADPH or tetrahydrobiopterin.  Native CaM and 
engineered CaM homologs with duplicated C-terminal (CaMCC) and N-terminal (CaMNN) lobes 
displaced [125I]CaM with Ki values in the low nM range. CaMNN supported nNOS catalysis, but 
required ~5-fold more calcium for comparable activity with native CaM, while nNOS activity was 
inhibited by CaMCC.  Taken with results from kinetic analyses of [125I]CaM association and 
dissociation at various concentrations of free Ca2+, our finings suggest four sequential steps in 
activation of nNOS by CaM: (1) Ca2+  binds to CaM’s C-lobe, (2) the C-lobe of CaM binds NOS, (3) 
Ca2+ binds to the N-lobe of nNOS-bound CaM, (4) the N-lobe of CaM binds nNOS.  Activation of 
nNOS only occurs after completion of step (4), with the displacement of nNOS’s autoinhibitory insert.  
Upon intracellular Ca2+ sequestration, deactivation of nNOS would proceed in reverse order, resulting 





 Nitric oxide (NO) is a key cell signaling molecule, which is, synthesized from L-arginine by a 
family of three mammalian NO synthase (NOS) gene products (Nathan and Xie, 1994; Griffith and 
Stuehr, 1995).  While NOS isoforms differ in their localization and modes of regulation, all share a 
requirement that calmodulin (CaM) be bound for enzyme activity.  Indeed, appreciation of a 
requirement for CaM was essential to the first purification of a NOS isoform (Bredt and Snyder, 1990).  
A 20 - 30 amino acid CaM-binding sequence that is both basic and hydrophobic is prototypic of 
Ca2+/CaM activated enzymes ( Cohen and Klee, 1988).  In NOSs, this CaM-binding sequence resides 
at the juncture between N-terminal oxygenase and C-terminal reductase domains ( Bredt and Snyder, 
1990; Liu and Gross, 1996).  All NOSs are obligate homodimers ( Griffith and Stuehr, 1995) and thus 
have a possibility for binding two molecules of CaM per dimer.  Indirect evidence suggests that CaM 
binding triggers NOS catalysis by eliciting a reorientation of heme and flavin cofactors within 
oxygenase and reductase domains, respectively, thereby promoting interdomain and intradomain 
electron flux ( Abu-Soud et al., 1993, 1994).  CaM was shown to gate electron flux in trans, i.e., 
between the reductase and oxygenase domains of companion subunits, providing a molecular 
explanation for the experimental finding that dimerization is essential to nNOS function (Siddhanta et 
al., 1998).  The ability of CaM to gate electron flux is associated with the displacement of a putative 
regulatory polypeptide within the FMN-binding domain of nNOS ( Salerno et al., 1997).  
 Neuronal NOS and eNOS, named for the neuronal and endothelial cells in which they were 
first described, are constitutively-expressed isoforms of NOS which are catalytically dormant until 
CaM binding is triggered by transient elevations in intracellular Ca2+.  Basal levels of intracellular Ca2+ 
are typically 50 - 100 nM, whereas during cell activation Ca2+ levels approach 1 µM.  Accordingly, in 
vitro studies have shown that nNOS and eNOS are both inactive at basal intracellular levels of Ca2+, 
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and activity increases as Ca2+ levels rise with EC50 values for Ca2+ of 250 to 350 Nm (Bredt and 
Snyder, 1990;, Schmidt et al., 1991).  Thus, nNOS and eNOS are perfectly poised for regulation by 
changing levels of intracellular Ca2+ concentration, in the physiological range.  In contrast, the 
inducible isoform of NOS (iNOS) contains CaM that is bound tightly, even at low resting levels of 
intracellular Ca2+ (Cho et al., 1992), explaining the apparent Ca2+-independence of this isoform.    
 CaM is a 17 kD protein composed of an 8-turn central α-helix, flanked by globular N- and C-
terminal Ca2+-binding lobes (Babu et al., 1988). Two helix-loop-helix structural motifs (EF-hands) are 
present per lobe, each with a capacity for binding a single Ca2+ atom (Manalan and Klee, 1984).  
Binding of Ca2+ causes compaction of the lobes, exposing hydrophobic and acidic residues, which 
engage in binding to cognate regulatory sites on target protein (Weinstein and Mehler, 1994).  Since 
strong positive cooperativity for Ca2+ binding occurs within lobes, but little or none between lobes, 
CaM species will predominate that contain neither or both Ca2+ atoms bound to a given lobe ( 
Weinstein and Mehler, 1994).  Notably, the C-lobe of CaM binds Ca2+ with 5- to 10-fold higher 
affinity than the N-lobe (Linse et al., 1991).. Once CaM is bound to a protein target, the affinity of 
Ca2+ for each lobe can increase substantially and differentially (Johnson et al.,1996).   
 Both the Ca2+-bound N- and C-lobes of CaM are independently able to bind nNOS (Persechini 
et al., 1994).  While the C-lobe compacts into its nNOS-binding mode at lower concentrations of Ca2+ 
than needed for N-lobe compaction, binding of the N-lobe was reported to be essential for nNOS 
activation (Persechini et al., 1996a).  Factors that regulate CaM binding to nNOS and the precise 
sequence of CaM-binding events involved in NOS activation and deactivation await definition.  
 The present studies were performed to elucidate details of CaM binding and control of nNOS 
activity.  We demonstrate that CaM binds in a calcium-dependent manner to a single class of non-
interacting sites on nNOS.  CaM initially binds to nNOS via its C-lobe, and subsequently activates 
catalysis by engaging its N-lobe.  A sequential model for activation and deactivation of nNOS is 
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inferred that has important implications for our appreciation of physiological nNOS 
activation/deactivation kinetics. 
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MATERIALS AND METHODS 
 
Materials  High purity bovine brain calmodulin and protein S-100 were purchased from Calbiochem 
(San Diego, CA).  Bolton-Hunter labeled [125I]CaM (sp. act. 1395 Ci/mmol) was obtained from NEN 
Life Sciences (Boston, MA). Rat recombinant nNOS was expressed in E. coli and purified as 
previously described (Roman et al., 1995).  The concentration of nNOS was quantified based on 
spectrophotometric determination of heme chromophore content, after heme reduction with 
dithiothreitol and CO binding (McMilla and Masters, 1993).  Engineered CaM analogs, CaMNN (in 
which CaM residues 82-148 have been replaced by residues 9-75) and CaMCC (in which CaM 
residues 9-75 have been replaced by residues 82-148) were kindly provided by Dr. A Persechini and 
prepared as previously described (Persechini et al., 1996a).  Tetrahydrobiopterin (BH4) was purchased 
from Schirks Laboratory (Jona, Switzerland).  Fura-2 and calcium standard solutions were from 
Molecular Probes (Eugene, OR). Microtiter plates with GF/B filtration membranes were from 
Millipore (Bedford, MA). Troponin C, nitrate reductase, lactic dehydrogenase and all other chemicals 
were from Sigma (St. Louis, MS). 
 
Binding of [125I]Calmodulin  Binding assays were performed in 96-well microfiltration plates 
containing GF/B membranes that had been pre-washed with buffer A [Tris-HCl (50 mM), CaCl2 (100 
µM; omitted in experiments where effects of calcium concentration were under investigation) and β-
lactoglobulin (0.5%), pH 7.6].  Incubations contained buffer A, DTT (1 mM), [125I]CaM (1 nM) 
(except for saturation analyses) and desired additions in a final volume of 100 µl.  Addition of nNOS 
(final concentration 10 nM) typically initiated the 15-minute binding reaction, conducted at 23°C. 
Binding experiments were terminated by rapid vacuum filtration followed by two washes with 100 µl 
of ice-cold buffer A.  Plates were air-dried and 25 µl scintillation cocktail was added to each well 
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(OptiPhase SuperMix, Wallac).  Bound radioactivity was determined using a Microbeta Plus liquid 
scintillation counter (Wallac).  Non-specific binding was defined by inclusion of either EGTA (5 mM) 
or unlabeled CaM (1 µM) and typically accounted for <10% of total [125I]CaM bound.  Ca2+-EGTA 
buffers were prepared to approximate the desired test concentrations of free Ca2+ using a standard 
protocol (Fabiato and Fabiato, 1979). Actual free Ca2+ concentration of buffers was specified by 
ratiometric fluorometry using fura-2 (1 µM) and a Fluorolog-2 spectrofluorimeter (SPEX; Edison, NJ). 
Preparation of MOPS/Ca2+ buffers 
Calcium buffers were prepared by mixing MOPS (10 mM) pH 7.2, KCl (100 mM)  EGTA (10 mM) 
with MOPS/KCl/EGTA and Ca2+ (10 mM).  
Assay of NOS activity based on NADPH Consumption  NADPH consumption by nNOS was assessed 
at 25°C in 96-well microtiter plates, as previously described (Gross, 1996).  Incubation mixtures 
contained Tris-HCl (50 mM), CaCl2 (100 µM), BH4 (10 µM), NADPH (500 µM), L-arginine (500 
µM), DTT  (1 mM) and calmodulin (100 nM) (in the absence or presence of CaMCC (100 nM), or 
CaMNN (100 nM) (pH 7.6), in a final volume of 100 µl.   Reactions were initiated by the addition of 
nNOS (100 nM) and the rate of A340 decrease was measured at 15-s intervals for a period of 30 min in 
a kinetic microplate spectrophotometer (Molecular Devices; Menlo Park, CA). 
Assay of NOS activity based on NOx Production NO synthesis was determined from nitrite + nitrate 
(NOx) accumulation in reaction mixtures.   NOx was quantified by the method of Griess, following 
enzymatic reduction of nitrate to nitrite and oxidation of residual NADPH. 
 
Analysis of Radioligand Binding Data  Binding parameters were assessed by computer-assisted non-
linear least squares regression analysis, using the Prism2 program (GraphPad Software Inc.) to fit the  
equation:    
B = (Bmax + T +Kd) /2 – {[(Bmax + T +Kd) /2]2 – BmaxT}1/2 
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B is the amount of bound [125I]CaM (in dpm), Bmax is the maximal binding density for  CaM on nNOS, 
T is the total concentration of [125I]CaM (in dpm) and Kd is the dissociation constant of CaM. This 
equation derives from the basic equilibrium formula [L][Bmax]/[B] = Kd, under the specialized 
condition where free ligand concentration (L) is significantly less than T, due to formation of 
complexes, B.  Analysis of association and dissociation kinetics of CaM binding and comparison of 
one- site vs. two-site binding models was performed using the Ligand  program (Biosoft, Cambridge, 
UK) and Prism2. 
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RESULTS AND DISCUSSION 
  While the pivotal role of CaM as a regulator of NOSs is well established, knowledge of the 
quantitative relationship between binding and NOS activation is limited.  Prior analyses of CaM 
binding to target proteins, including nNOS, have utilized indirect methods such as activation of 
enzyme activity or altered intrinsic protein fluorescence resulting from CaM occupancy (Bredt and 
Snyder, 1990: Sheta et al.,1994). As a consequence of limited assay sensitivity, these approaches 
usually require that the target protein is present in great excess over the Km for CaM binding; this 
results in diminished precision in determining CaM binding affinity due to uncertainties in the 
calculation of free [CaM].  Moreover, the use of activity as a surrogate marker for binding assumes a 
1:1 ratio between binding and activity, which is not necessarily the case.  Alternatively, direct binding 
of [125I]CaM has been investigated using protein targets bound to nitrocellulose membranes;(Edlund et 
al., 1996; Hubbard and Klee, 1987) or by western blot analysis of protein/CaM immunoprecipitates 
(Presta et al., 1997; Ruan et al., 1996. This solid-phase approach is limited in practice to the analysis of 
few samples, is neither highly reproducible nor amenable to the analysis of binding kinetics, and can 
give results that poorly reflect actual binding events in solution.  For greater precise, high-throughput 
and rapid analysis of CaM binding to purified nNOS, we sought to develop a solution-phase 
radioligand assay using [125I]CaM in a 96-well microfiltration plate format.   
 Preliminary experiments demonstrated that upon vacuum filtration through GF/B membranes, 
nNOS/[125I]CaM complexes are retained while blank binding is less than 0.01% of free [125I]CaM.  A 
high single-pass extraction efficiency of nNOS/[125I]CaM complexes by GF/B membranes was 
indicated by our observation that two additional re-passages of the flow-through resulted in < 5% 
additional retention of radiolabeled complexes on the GF/B filters (beyond that measured after the 
initial passage). Thus, filtration through 96-well  GF/B filter-bottom microtiter plates was validated as 
an effective and reliable means to quantify solution-phase binding of [125I]CaM to purified nNOS. 
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Affinity, specificity and influence of substrates/cofactors on CaM binding to nNOS.   As shown in Fig. 
1A, the binding of [125I]CaM (1 nM) to nNOS (10 nM) progressed in a monophasic manner with time, 
reaching apparent equilibrium with a t1/2 of < 2 min at 23°C. In the presence of 0.1 pmol [125I]CaM, 
complex formation increased linearly with added [nNOS], until saturation was approached with >95% 
of added [125I]CaM engaged in complex with nNOS (Fig. 1B).  The hyperbolic fit observed in Fig. 1B 
reveals that [125I]CaM bound to a finite number of specific binding sites on nNOS. 
 Analysis of saturation binding experiments revealed that [125I]CaM binds to a single class of 
high affinity binding sites on nNOS with a Kd = 4.70 ± 0.47 nM  (n=8; Fig. 2).  Maximal binding was 
observed at a stoichiometry of [125I]CaM to nNOS heme chromophore that approached 1.0 (Fig. 2).  
The observed maximal stoichiometry of 1.0, and goodness-of-fit to a single hyperbolic function, 
indicates that CaM binds to each subunit of the nNOS homodimer with an equivalent affinity.  Thus, 
although CaM binding has been demonstrated to act both within and between nNOS subunits to 
promote electron flux (Abu-Soud et al., 1993, 1994; Siddhanta et al., 1996b), no evidence for site-to-
site cooperativity was detected.  The observed Kd of 4.70 nM for CaM binding to holo-nNOS confirms 
and refines an earlier estimate of 1 nM, based on binding-induced changes in intrinsic tryptophan 
fluorescence of nNOS (Sheta et al., 1994), and is in accord with reports of a 1-3 nM affinity for CaM 
binding to nNOS-derived peptides (Vorherr  et al., 1993; Zhang  and Vogel, 1994).  
 Substrates and cofactors of nNOS were tested for their influence on [125I]CaM binding.  
Inclusion of 10 µM concentrations of NADPH, BH4 and L-arginine, individually and in combinations, 
resulted in no significant effect on [125I]CaM binding (results not shown); notably these concentrations 
all exceed the respective Km values for ligand binding ( Griffith and Stuehr, 1995).  Higher 
concentrations of NADPH and L-arginine (0.1 and 1 mM each) were similarly without effect on 
[125I]CaM binding (results not shown). These findings suggest that substrate/cofactor occupancy of the 
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active site of nNOS does not elicit allosteric effects on key CaM-binding residues sufficient to 
manifest as a macroscopic effect on CaM binding affinity.  In contrast, BH4 is reported to be an 
allosteric modulator of recombinant rat nNOS and required for high affinity binding of arginine 
analogs (Alderton et al., 1998: Liu and Gross, 1996; Roman  et al.,1995).  Moreover, maximal 
[3H]tetrahydrobiopterin binding to nNOS has been reported to require arginine occupancy (Alderton et 
al., 1998; Gorren et al., 1996; Liu and Gross, 1996). Thus, although CaM binding clearly alters the 
active site environment of nNOS, allowing for electron gating from FMN to heme, our findings 
suggest that active site substrates do not elicit a detectable effect on CaM binding characteristics. 
 Specificity of the CaM binding site on nNOS was investigated by comparing the ability of 
native CaM, other calcium-binding proteins, and engineered CaM analogs, to compete for binding of 
[125I]CaM.  Since previous studies suggested that calcium-binding proteins displace [125I]CaM from 
CaM-activated enzymes such as nNOS (Su et al., 1995), the relative ability of troponin C and protein 
S-100 to compete with [125I]CaM was examined (Fig. 3).  Troponin C was an effective competitor but 
exhibited relatively low potency, with an IC50 value of 5.9 µM.  On the other hand, the ubiquitous 
calcium binding protein of brain, S-100, was completely inactive as a CaM competitor at 
concentrations up to 30 µM.  Thus, the CaM binding site on nNOS exhibits a high degree of selectivity 
for CaM. 
 Native CaM and engineered CaM analogs that contain either duplicated C-lobes or N-lobes, 
namely CaMCC and CaMNN, inhibited [125I]CaM binding to nNOS with Ki values of 4.37 ± 1.12 
(n=7), 31.01 ± 5.03 (n=3) and 4.97 ± 0.86 (n=6) nM, respectively (Fig. 4).  The 6-7 fold  lower affinity 
of CaMCC for nNOS, relative to native CaM and CaMNN, suggests that the C-lobe of CaM may not 
dock effectively with binding sites on nNOS that interact normally with the N-lobe of native CaM.  
Moreover, a diminished Hill coefficient for binding CaMCC (0.77 ± 0.17), relative to the Hill 
coeficients for the binding of native CaM (1.34 ± 0.22) and CaMNN (1.30 ± 0.20), suggests that the C-
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lobe of CaM may actually sustain anti-cooperative interactions with sites on nNOS that interact with 
the N-lobe of native CaM.  In contrast, the similar affinity and Hill coefficients for binding CaMNN 
and native CaM suggest that the N-lobe of CaM can effectively interact with sites on nNOS that 
normally interact with the C-lobe of native CaM. While the order of CaMNN and CaMCC binding 
affinity described above is opposite to that previously reported for nNOS (Persechini et al., 1996a), it 
is notable that the latter determination was indirect, i.e., deduced from enzyme activity measurements 
rather than direct analysis of binding. 
 Activity studies showed that CaMNN faithfully mimics the ability of native CaM to promote 
electron transfer in nNOS, monitored as an increase in NADPH consumption rate (data not presented).  
On the other hand, an increase in NADPH consumption was not observed at a concentration of 
CaMCC that occupies >80% of CaM binding sites on nNOS.  Indeed, the addition of CaMCC in 10-
fold molar excess over native CaM resulted in a >70% inhibition of NADPH consumption (results not 
shown).  These observations are in accord with the earlier finding (Persechini et al., 1996a) that a CaM 
with duplicated C-lobes can bind but not activate nNOS, whereas a CaM with duplicated N-lobes 
supports both binding and catalytic activity.  Since 2-D NMR studies have demonstrated that the N-
terminal lobe of CaM binds to the C-terminal aspect of the CaM binding site of nNOS (Zhang et al., 
1995), we infer that it is this specific interaction that is crucial for activation of nNOS by CaM.   
Notably,0 it is also the C-terminal aspect of the CaM binding site that is in closest proximity to the 
FMN-domain regulatory control-element whose displacement by CaM was identified and proposed to 
mediate calcium-dependent NOS activation (Saleno et al., 1997).  Function of the proposed regulatory 
control element was recently confirmed for both eNOS (Nishida and de Montellano, 1999) and nNOS 
(Daff  et al.,1999).  Thus, the N-lobe of CaM is essential for nNOS activity and, when bound to nNOS, 
is poised to engage in putative control-element interactions that may serve to release the proposed 
autoinhibition of nNOS activity. 
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Calcium-dependence of CaM binding and nNOS activation.  The calcium-dependence of [125I]CaM 
binding to nNOS was directly assessed using a series of calcium-EGTA buffers for precise control of 
free Ca2+ concentration. The amount of [125I]CaM bound to nNOS under equilibrium conditions 
increased as a function of free [Ca2+], with half-maximal binding achieved at 202 ± 61 nM) (n = 5; 
dashed line, open circles in Fig. 5).  Minimal CaM binding was detectable at < 16 nM free [Ca2+] and 
binding approached a maximal level at 1 µM [Ca2+].  Further increase in free [Ca2+] from 10 µM to 1 
mM resulted in a 24% reduction from maximal CaM bound (n = 2, data not shown), consistent with 
the decline in nNOS activity reported by Bredt and Snyder (1990) at similarly high concentrations of 
Ca2+. This loss of CaM binding with high [Ca2+] may involve binding of Ca2+ to additional weak 
affinity sites on CaM that have recently been identified (Gilli  et al., 1998).  The Hill coefficient for 
Ca2+-dependence of [125I]CaM binding to nNOS was 1.22 ± 0.24, not significantly different from unity.  
Surprisingly, the EC50 of calcium for support of nNOS catalytic activity was significantly greater than 
that required for support of [125I]CaM binding.   As shown in Fig 5, the curve which reflects the Ca2+-
dependence of nNOS activity (solid line, filled circles) lies to the right of that for Ca2+-induced CaM 
binding exhibiting an EC50 value of 447 ± 13 nM, (n = 5). 
The conspicuous non-identity of binding and activation curves can be reconciled by the 
existence of at least two modes of CaM binding to nNOS: at low levels of Ca2+ (< 100 nM) a 
CaM/nNOS complex can form that is devoid of catalytic activity, whereas at higher levels of Ca2+ the 
activated nNOS complex results.  We questioned the molecular identity of these two postulated 
complexes.  Given that the C-lobe of CaM compacts into its protein-binding conformation at 5 to 10-
fold lower Ca2+ than that needed for N-lobe compaction (Linse et al., 1991), and the C-lobe alone is 
insufficient for nNOS activation, we hypothesized that the catalytically non-productive complex may 
result from exclusive binding of CaM's C-lobe.  However, when Ca2+ concentrations are sufficiently 
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high to compact both C- and N-lobes, permitting each lobe to simultaneously bind nNOS, critical N-
lobe interactions may elicit the activated nNOS complex.  Consistent with the higher concentration of 
Ca2+ required for compaction and binding of N-lobes (relative to C-lobes), the EC50 of Ca2+ for 
activation of nNOS by CaMNN was found to be 2.66 ± 0.42 µM (n = 3), approximately five-fold 
higher than that for native CaM.  Taken together, these findings suggested that the existence of two 
distinct nNOS/CaM complexes: one that is catalytically inactive, formed at low levels of Ca2+ and 
involves C-lobe interactions only, and a second that is catalytically active, formed at higher 
concentrations of Ca2+ and involves both C- and N-lobe interactions.  This “stepwise” binding 
hypothesis was tested by studies of the effects of Ca2+ concentration on CaM binding kinetics. 
 
Calcium-dependence of kinetics for CaM binding to nNOS.  Levels of free Ca2+ dictate the extent to 
which the C- and N-lobes of CaM are compacted in a conformation suitable for nNOS binding. 
Association rates for [125I]CaM binding to nNOS were quantified at each of several free [Ca2+]. As 
expected, on-rates were found to increase progressively with increasing Ca2+ concentration; t1/2 values 
of 1.549 ± 0.163, 0.603 ± 0.201 and 0.414 ± 0.098 min were observed with 0.08, 0.23 and 6.2 µM 
Ca2+, respectively (in the presence of 1 nM CaM and 10 nM nNOS; n = 3 for each concentration).  
Accuracy of kinetic measurements is limited by an assay dead time estimated to approach 0.1 min.  
Increasing [Ca2+] also enhanced the levels of equilibrium [125I]CaM binding to nNOS, achieving  
approximately 22, 56 and 100% of maximal levels, respectively (data not shown). 
 Rates of [125I]CaM dissociation from complexes with nNOS were determined upon addition of 
a 1000-fold molar excess of unlabeled CaM. When [125I]CaM/nNOS complexes were formed in the 
presence of a concentration of Ca2+ that elicits maximal CaM binding and nNOS activation (6.2 µM), 
dissociation of [125I]CaM occurred at a monophasic exponential rate with t1/2 = 54.2 ± 7.6 min (Fig. 6 
and summary data in Table 1).  An indistinguishable monophasic dissociation rate was observed when 
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[125I]CaM/nNOS complexes were formed using a still greater excess of Ca2+ (100 µM; dissociation t1/2 
= 48.8 ± 13.2 min).  However, when [125I]CaM/nNOS complexes were formed in the presence of 0.23 
µM Ca2+, a concentration that supports approximately 50% of maximal CaM binding, two distinct 
temporal phases of dissociation were observed (Fig. 6 and Table 1).  Whereas 52.6% of the 
[125I]CaM/nNOS complexes formed at 0.23 µM Ca2+ dissociated within 2 min (t1/2 =  0.74 ± 0.36 min; 
n = 3), the remaining 47.4% dissociated at a substantially slower rate (t1/2 = 24.6 ± 7.6 min; n=3) that 
was not significantly different from the singular dissociation rate observed with high [Ca2+].    
In additional experiments, the rate of dissociation of [125I]CaM/nNOS complexes was assessed 
after free [Ca2+] was diminished to a specified level by chelation with EGTA; this is akin to actual 
cellular regulation and therefore affords a more physiologically relevant approach to the analysis of 
CaM dissociation.  Rapid reduction of calcium concentration from 6.2 to 0.23 µM, concomitant with a 
10-fold dilution of incubates, elicited biphasic dissociation kinetics; a rapid component involved >50% 
of complexes (t1/2 = 0.205 min, n = 3), and a much slower phase followed (t1/2 of 13.993 min, n=3; data 
not shown).    
Biphasic dissociation kinetics of insect CaM from a variety of CaM-binding peptides have 
similarly been observed using stopped-flow measurements after calcium-chelation (Brown et al., 
1998); dissociation by a combination of partially calcium-occupied CaM and calcium-devoid CaM was 
indicated to be responsible for the biphasic phenomenon.  Studies of chelator-induced calcium 
dissociation from CaM/nNOS complexes, in which calcium levels are driven to essentially zero 
(Persechini et al., 1996b), demonstrated that of 4 bound calcium ions, two dissociate rapidly from the 
N-lobe of CaM, at a rate exceeding 1000   s-1, whereas the additional two dissociate slowly from the C-
lobe, at 1 s-1.  Thus, ample evidence favors the view that CaM can dissociate from nNOS, and perhaps 
other CaM-binding proteins, in either of two modes depending on free [Ca2+]: one in which only the C-
lobe of CaM has bound calcium and a second in which both N- and C-lobes of CaM are devoid of 
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calcium.  Reciprocally, CaM association with nNOS should similarly involve binding of two distinct 
species whose relative concentrations would be determined by free Ca2+, one with Ca2+ bound only to 
the C-lobe of CaM (most abundant at low intracellular Ca2+) and a second with Ca2+ bound to both N- 
and C-lobes of CaM (most abundant at high intracellular Ca2+).  Interestingly, a small-angle scattering 
study of CaM binding to myosin light chain kinase (MLCK) demonstrated that CaM binding to this 
enzyme occurs at substoichiometric [Ca2+] (Krueger et al., 1998).  While CaM was shown to bind to 
MLCK at Ca2+ concentrations lower than 2 mol/mol of CaM, compaction and activation required 
saturating [Ca2+]. 
 Taken together, our findings are reconciled by a sequential model that describes the 
relationship between binding and activation of nNOS by CaM (Fig. 7).  The model reflects an 
appreciation of the independent contributions of the two lobes of CaM to formation, stabilization and 
catalytic activation of CaM/nNOS complexes.  Analyses of [125I]CaM/nNOS association and 
dissociation kinetics suggest four successive and distinct steps in binding/activation of nNOS by CaM.   
In step 1, an intracellular Ca2+ transient results in an increase in [Ca2+]i, and preferential binding of 2 
mols of Ca2+ to EF-hand pairs within the C-terminal lobe of CaM.  This results in a compaction of the 
C-lobe and exposure of residues that are acidic and hydrophobic for high-affinity binding interactions, 
in step 2, with the N-terminal aspect of the CaM binding site on nNOS.   The resulting species is 
proposed to explain catalytically inactive [125I]CaM/nNOS complexes detected at low levels of Ca2+ 
(i.e., ≤ 100 nM).  As [Ca2+]i continues to rise, additional 2 mols of Ca2+ can saturate EF-hand pairs 
within the N-terminal lobe of nNOS-bound CaM (step 3).   This triggers in situ compaction of the N-
lobe of CaM, revealing amino acid residues that can engage the C-terminal aspect of the CaM binding 
site on nNOS (step 4).  Activation of catalytic activity would occur only after completion of this final 
step.  Based on reported structures of CaM bound to cognate peptides from myosin light chain kinase 
(Meador et al., 1992, 1993) and CaM-dependent protein kinase II (Ikura et al., 1992), it is presumed 
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that the lobes of Ca2+-saturated CaM envelope the CaM-binding peptide of nNOS, resulting in nNOS 
activation via reorientation of inter- and intra-subunit heme and flavin cofactors.  This structural 
reorganization is proposed to occur in association with a displacement of the autoinhibitory control 
peptide. It is notable that three-dimensional homology-based modeling indicates that the control 
peptide occupies space that is adjacent to or overlapping the site where CaM’s N-lobe interacts with 
nNOS (Salerno et al., 1997).  The identity of residues within the N-lobe of CaM that may contribute to 
displacement of the autoinhibitory peptide in nNOS await specification.   
 Upon intracellular Ca2+ sequestration, deactivation of nNOS would proceed in reverse order.  
Since Ca2+ dissociates orders of magnitude faster from the N-lobe than the C-lobe of nNOS-bound 
CaM (Persechini et al., 1996b), and N-lobe binding is essential for nNOS activity, Ca2+ dissociation 
from the N-lobe would control nNOS activity.  Thus, the initial phase of Ca2+ dissociation from the N-
lobe of CaM would result in inactive nNOS with CaM bound only by C-lobe interactions.  As the 
affinity of Ca2+ for CaM may be significantly increased for NOS-bound CaM, relative to NOS-free 
CaM (Persechini et al., 196b), the concentration of free Ca2+ that elicits half-maximal complex 
dissociation may be significantly less than that required for half-maximal complex formation.  Thus, 
hysteresis in the Ca2+-dependence for nNOS binding and unbinding of CaM is anticipated.  Our 
finding that significant levels of catalytically inactive [125I]CaM/nNOS complexes can be formed in 
vitro in the presence of 50-100 nM Ca2+, makes it likely that these species would also predominate in 
cells at resting levels of intracellular [Ca2+].  Our findings lend direct support for the view that rapid 
Ca2+ dissociation from the N-terminal lobe of CaM would elicit enzyme inactivation without triggering 
dissociation of the CaM-nNOS complex, proposed in earlier stopped-flow fluorescence studies of 
calcium dissociation from CaM, bound to a nNOS-derived peptide (Persechini et al., 1996b).  
 An important implication of the above scenario is that some nNOS would be replete with 
ineffectually-bound CaM in cells at rest, and thus reside in a state that is primed and ready for rapid 
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activation upon exposure to an intracellular calcium transient.  Evolution may have favored pre-bound 
CaM as a means to endow nNOS with an enhanced temporal responsiveness to physiological stimulus-
evoked changes in free [Ca2+] in neurons, skeletal muscle and other nNOS-containing tissues.  This 
situation is not likely to be unique to nNOS; it has been speculated earlier that in some other CaM-
regulated enzymes high C-lobe binding affinity may result in CaM binding in vivo, at resting levels of 
free [Ca2+]i (Meador et al., 1992). 
 In conclusion, we have used a novel radioligand binding assay to perform the first direct 
quantitative analysis of CaM binding to a NOS isoform.  Conceivably, this technique will also have 
utility for the analysis of CaM interactions with other high-affinity CaM-binding proteins.  In addition 
to defining Kd, Ca2+-dependence and the potential influence of cofactors and other calcium-binding 
proteins on CaM/nNOS interactions, this approach has enabled us to perform a direct assessment of the 
relationship between CaM binding and nNOS activation.  Our findings reveal that CaM can bind to 
nNOS at low basal levels of intracellular calcium without triggering NO production.  Molecular details 
of subsequent interactions, specifically those involving the N-lobe of CaM that are critical for NOS 
activation, will be the key to a future understanding of how CaM gates electron flux in NOSs. 
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Table 1. Influence of [Ca2+] on the kinetics of [125I]CaM dissociation from nNOS. 
  
             Site 1             Site 2   
[Ca2+] (µM) N t1/2 (min) % total sites t1/2 (min) % total sites r2 
       100 3 48.8 ± 13.22 100 - - 0.931 
6.2 3 54.24 ± 7.58 100 - - 0.921 
0.23 4 24.59 ± 7.59 52.6 ± 12.23 0.74 ± 0.36 47.4±15.70 0.994 
 
 
[125I]CaM (1 nM) was incubated for 30 minutes at 23°C with nNOS (10 nM) to elicit complex 
formation.  Dissociation of complexes was initiated by the addition of excess unlabeled CaM (1 µM). 
All values are means ± SEM. The number of experiments performed is denoted by N and the mean 
correlation coefficient for non-linear least squares fit to one-site or two-site models of dissociation are 




Figure 1.  Binding of [125I]CaM to purified rat nNOS.  Panel A: Time course of [125I]CaM (1 nM) to 
nNOS (10 nM) at 23°C (for details, see Materials and Methods). The reaction was initiated by the 
addition of nNOS and terminated by rapid vacuum filtration at the indicated times. Data points 
represent means ± SEM of specific [125I]CaM bound (n = 5).  Panel B: Effect of increasing [nNOS] on 
the formation of nNOS/[125I]CaM complexes, after a 30 min incubation with 0.1 pmol [125I]CaM (1 
nM final concentration).  Data points represent means ± SEM for triplicate determinations of 
specifically-bound [125I]CaM.  Similar results were obtained in 3 independent experiments.  
 
Figure 2.   Saturation binding of [125I]CaM to nNOS. Increasing concentrations of [125I]CaM were 
incubated with nNOS (10 nM) and binding reactions were terminated after a 30 min incubation.   The 
Kd for specific [125I]CaM bound to nNOS was determined by nonlinear regression analysis using an 
algorithm that accounts for depletion of free ligand as a result of binding (for details, see Materials 
and Methods).  The computer-fit binding parameters are given on the plot.  Eight independent analyses 
yielded similar results, with r2 > 0.95 and a mean Kd value of 4.70 ± 0.47 nM.  The inset depicts a 
Scatchard plot of the given data, consistent with a single class of binding sites and a stoichiometry of 1 
mol [125I]CaM bound per mol of nNOS.   
 
Figure 3.  Specificity of [125I]CaM binding to nNOS: competition for binding by other calcium binding 
proteins. Calmodulin (circles), Troponin C (stars) or protein S-100 (diamonds) were added at the 
indicated concentrations to incubation mixtures containing [125I]CaM (1 nM) and nNOS (10 nM). 
Incubations were performed as described in Materials and Methods and data points are mean ± SEM 
values of triplicate determinations.  Similar results were obtained in 4 independent experiments. 
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Figure 4. Competition by engineered CaM proteins with [125I]CaM for binding to nNOS. CaMNN 
(residues 82-148 replaced by residues 9-75; squares), CaMCC (residues 9-75 replaced by residues 82-
148; triangles) or native CaM (circles) were incubated at the indicated concentrations with nNOS (10 
nM) and [125I]CaM (1 nM) as described in Materials and Methods. Data represent mean ± SEM values 
of triplicate determinations.  Similar results were obtained in 3-7 separate experiments. 
 
Figure 5. Effect of free calcium concentration on binding of [125I]CaM (100 nM) to nNOS (100 nM) 
and activation of nNOS by native CaM and CaMNN. Ca2+ concentrations were controlled using 
calcium-EGTA buffers and were quantified by FURA-2 fluorescence, as described in Materials and 
Methods.  CaM binding data are indicated by the dashed line and open circles and are represented on 
the ordinate as % total binding.  Activity of nNOS (100 nM) was measured as nitrite production during 
a 30-min period of incubation with CaM (100 nM; filled circles) or CaMNN (100 nM; filled squares) 
and buffer yielding the indicated concentration of free Ca2+.  All points are means ± SEM of triplicate 
determinations.  
 
Figure 6. Dissociation of [125I]CaM from complexes with nNOS formed at differing concentrations of 
free Ca2+.  [125I]CaM (1 nM) was incubated with nNOS (10 nM) for 15 min at 0.23 µM and 6.2 µM 
calcium ion concentrations. Dissociation was induced by addition of 1 µM native unlabeled CaM. 
Points are means ± SEM values of triplicate determinations. 
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